Sign In
Buy CRSP
CRISPR Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -40.87. In total, the insiders bought 1.36M and sold 326.14K CRSP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-40.87 |
| ● Buy | 1.36M shares |
| ● Sell | 326.14K shares |
|
70% Buy Activity
Moderate Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 05, 2026 Buy |
Treco Douglas A Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
Morrison Briggs Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
Fleming Harold Edward Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
Fardis Maria Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
Behbahani Ali Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
George Simeon Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
Greene John Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
High Katherine A Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
Mahatme Sandesh Director |
13 000 Value: $673.9K |
||
|
Jun 05, 2026 Buy |
Rommel Christian Director |
13 000 Value: $673.9K |
||
|
May 29, 2026 Buy |
Prasad Raju Chief Financial Officer |
19 500 Value: $1.10M |
||
|
May 29, 2026 Buy |
Kasinger James R. General Counsel And Secretary |
17 000 Value: $955.1K |
||
|
May 29, 2026 Buy |
Patel Naimish Chief Medical Officer |
22 000 Value: $1.24M |
||
|
May 29, 2026 Sell |
Patel Naimish Chief Medical Officer |
3 786 Value: $210.6K |
||
|
May 28, 2026 Buy |
Patel Naimish Chief Medical Officer |
10 000 Value: $563.8K |
||
|
May 28, 2026 Buy |
Patel Naimish Chief Medical Officer |
10 000 Value: $563.8K |
||
|
Mar 23, 2026 Sell |
Prasad Raju Chief Financial Officer |
3 708 Value: $173.5K |
||
|
Mar 23, 2026 Sell |
Kulkarni Samarth Chief Executive Officer |
10 020 Value: $468.7K |
||
|
Mar 23, 2026 Sell |
Kasinger James R. General Counsel And Secretary |
3 182 Value: $148.9K |
||
|
Mar 20, 2026 Buy |
Patel Naimish Chief Medical Officer |
30 000 Value: $1.39M |
||
|
Mar 20, 2026 Buy |
Prasad Raju Chief Financial Officer |
6 250 Value: $289.0K |
||
|
Mar 20, 2026 Buy |
Prasad Raju Chief Financial Officer |
6 250 Value: $289.0K |
||
|
Mar 20, 2026 Buy |
Prasad Raju Chief Financial Officer |
27 500 Value: $1.27M |
||
|
Mar 20, 2026 Buy |
Prasad Raju Chief Financial Officer |
38 499 Value: $1.78M |
||
|
Mar 20, 2026 Buy |
Kulkarni Samarth Chief Executive Officer |
19 687 Value: $910.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
